Peter Greenleaf, Chief Executive Officer at Aurinia Pharmaceuticals Inc. (AUPH), bought 5,125 shares at $10.15 ($55K) on 2021-05-11, disclosed to the SEC on 2021-05-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.15 | 2,133 | $22K | 39.4% |
| 2 | $11.11 | 2,992 | $33K | 60.6% |
| Total | $10.71 avg | 5,125 | $55K | 100% |
| Filing → |
| AUPH | SELL | 2025-03-04 | $4.2M | — | Filing → |
| AUPH | SELL | 2024-03-07 | $1.4M | — | Filing → |
| AUPH | SELL | 2024-02-22 | $580K | — | Filing → |